Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Chinese Medical Journal|July 1, 2020
Zinc finger and BTB domain-containing protein 46 is essential for survival and proliferation of acute myeloid leukemia cell line but dispensable for normal hematopoiesisYuan-Yuan Liu, Fei-Fei Xiao, Bi-Jie Yang, et al.Cancer Management and Research|September 15, 2018
Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinomaQiang-Hua Zhou, Chuang-Zhong Deng, Jie-Ping Chen, et al.Oncotarget|September 9, 2017
More precise prediction in Chinese patients with penile squamous cell carcinoma: protein kinase CK2α catalytic subunit (CK2α) as a poor prognosticatorZai-Shang Li, Chuang-Zhong Deng, Yun-Lin Ye, et al.Hematological Oncology|October 11, 2016
A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest ChinaRong Liang, Guang-Xun Gao, Jie-Ping Chen, et al.Cancer Communications (London, England)|March 4, 2020
Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patientsQiang-Hua Zhou, Hui Han, Jia-Bin Lu, et al.Oncotarget|March 17, 2016
Development of a new outcome prediction model for Chinese patients with penile squamous cell carcinoma based on preoperative serum C-reactive protein, body mass index, and standard pathological risk factors: the TNCB score group systemZai-Shang Li, Peng Chen, Kai Yao, et al.Cancers|December 10, 2021
Genome-Wide Profiling Reveals HPV Integration Pattern and Activated Carcinogenic Pathways in Penile Squamous Cell CarcinomaKang-Bo Huang, Sheng-Jie Guo, Yong-Hong Li, et al.The Journal of Clinical Investigation|August 31, 2021
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancerShini Liu, Qiong Zou, Jie-Ping Chen, et al.The Lancet. Haematology|May 26, 2019
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trialPeng-Peng Xu, Di Fu, Jian-Yong Li, et al.Journal of Cancer Research and Clinical Oncology|October 25, 2016
Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration studyZai-Shang Li, Chuang-Zhong Deng, Kai Yao, et al.Pageof 4